Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

March 1, 2000

Vintage Pharmaceuticals Recalls Q-V Tussin Elixir

Huntsville, AL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Vintage Pharmaceuticals, Inc. is recalling certain Q-V Tussin Elixir (Hydrocodone Bitartrate, Pseudoephedrine HCL and Chlorpheniramine Maleate), in 1-pint bottles, under the Qualitest and Vintage labels, because of lack of assurance chlorpheniramine maleate will maintain potency throughout labeled shelf life.

According to the FDA, over 47,000 units were distributed were nationwide and bear the following codes:

NDC # 0603-1609-58, Lot # 038D8A, EXP 04/00
NDC # 0603-1609-58, Lot # 035F8A, EXP 05/00
NDC # 0254-9403-58, Lot # 035F8B, EXP 05/00
NDC # 0603-1609-58, Lot # 004G8A, EXP 06/00
NDC # 0603-1609-58, Lot # 005G8A, EXP 06/00
NDC # 0603-1609-58, Lot # 006G8A, EXP 06/00
NDC # 0603-1609-58, Lot # 034M8A, EXP 11/00

This ongoing Class III recall was initiated by Vintage Pharmaceuticals, by letter dated January 28, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-220-0

Notice of this product warning was sent via email to SafeMail subscribers March 1, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.